磁共振直线加速器上无模拟定位自适应前列腺立体定向体部放疗:技术可行性与临床经验
该研究在磁共振直线加速器上开发并评估两种无模拟定位的前列腺癌立体定向体部放疗工作流程:一种使用诊断性磁共振参考扫描,另一种使用预先批准的模板扫描。基于人群的相对电子密度赋值导致平均剂量差异小于1%,人工智能轮廓与医生批准的轮廓高度一致,两种无模拟定位工作流程的自适应计划在剂量和机器跳数上与标准工作流程临床可比。基于诊断性磁共振的无模拟定位工作流程已在临床实施,治疗22例患者无失败。
要点
- 基于100例前列腺立体定向体部放疗患者的人群相对电子密度赋值,平均剂量差异小于1%。
- 人工智能轮廓与医生批准轮廓高度一致,膀胱、直肠、阴茎球和骨的表面Dice分别为0.96、0.98、0.99和0.99。
- 两种无模拟定位工作流程的自适应计划与标准工作流程临床可比,平均剂量差异为-1.7%至4.6%,平均机器跳数差异小于2%。
核心结论
- 两种无模拟定位工作流程均消除了模拟定位的需要,在不影响计划质量的情况下简化了自适应前列腺立体定向体部放疗。
- 基于模板的工作流程通过消除成像前提进一步改善了患者可及性。
研究设计与样本
- 研究在磁共振直线加速器上开发并评估两种无模拟定位前列腺立体定向体部放疗工作流程。
- 基于人群的相对电子密度值从100例前列腺立体定向体部放疗患者中导出,并在另外10例患者中验证剂量学等效性。
- 两种无模拟定位方法在另一独立10例患者队列中评估,参考计划分别来自诊断性磁共振扫描(5例回顾性、5例前瞻性)和基于人群相对电子密度的数字创建盆腔模体扫描(全部回顾性)。
- 使用表面Dice(1毫米容差)和附加路径长度研究自适应治疗期间人工智能生成轮廓的性能。
- 比较所有自适应计划(来自两种无模拟定位工作流程和临床交付工作流程)的剂量指标和机器跳数使用。
主要发现
- 基于人群的相对电子密度赋值导致平均剂量差异小于1%。
- 人工智能轮廓与医生批准轮廓高度一致,膀胱、直肠、阴茎球和骨的表面Dice/附加路径长度分别为0.96/26.2厘米、0.98/17.2厘米、0.99/0.4厘米和0.99/0.01厘米。
- 两种无模拟定位工作流程的自适应计划与标准工作流程临床可比,平均剂量差异为-1.7%至4.6%,平均机器跳数差异小于2%。
- 故障模式与影响分析识别出3个高风险故障模式:诊断性磁共振扫描标记错误(风险优先数=39)、病例追踪失误(风险优先数=29)和相对电子密度赋值错误(风险优先数=22),均通过工作流程改进和培训缓解。
- 基于诊断性磁共振的无模拟定位工作流程已临床实施,治疗22例患者无失败。
关键数值与推荐
- 基于人群的相对电子密度赋值导致平均剂量差异小于1%。
- 人工智能轮廓与医生批准轮廓的表面Dice/附加路径长度:膀胱0.96/26.2厘米,直肠0.98/17.2厘米,阴茎球0.99/0.4厘米,骨0.99/0.01厘米。
- 两种无模拟定位工作流程的自适应计划与标准工作流程的平均剂量差异为-1.7%至4.6%,平均机器跳数差异小于2%。
- 高风险故障模式的风险优先数:诊断性磁共振扫描标记错误=39,病例追踪失误=29,相对电子密度赋值错误=22。
- 基于诊断性磁共振的无模拟定位工作流程已治疗22例患者无失败。
临床怎么用
- 无模拟定位工作流程可简化自适应前列腺立体定向体部放疗,消除模拟定位需要而不影响计划质量。
- 基于模板的工作流程可消除成像前提,改善患者可及性。
- 实施时需关注诊断性磁共振扫描标记、病例追踪和相对电子密度赋值等高风险环节,并通过工作流程改进和培训缓解。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To develop and evaluate 2 simulation-free (SF) stereotactic body radiation therapy (SBRT) workflows for prostate cancer on magnetic resonance (MR)-Linac: one using a diagnostic MR reference scan and another using a preapproved template scan. METHODS AND MATERIALS: Population-based relative electron density (RED) values were derived from 100 prostate SBRT patients on the Elekta Unity MR-Linac and validated on a separate cohort of 10 patients for dosimetric equivalence. Two SF approaches were evaluated in another independent cohort of 10 patients using reference plans derived from: (1) a diagnostic MR scan (5 retrospective, 5 prospective), and (2) a digitally created pelvic phantom scan using population-based RED (all retrospective). The performance of artificial intelligence-generated contours was investigated during adaptive treatments using surface Dice (sDSC) with 1 mm tolerance and added path length. All adaptive plans, from both SF and the clinically delivered workflow, were compared in terms of dose metrics and monitor unit usage. A focused failure modes and effects analysis identified and mitigated diagnostic MR SF-specific risks by calculating the risk priority number (RPN). RESULTS: Population-based RED assignments resulted in mean dose differences under 1%. Artificial intelligence contours showed strong agreement with physician-approved contours, with sDSC and added path length of 0.96/26.2cm,0.98/17.2cm,0.99/0.4cm, and 0.99/0.01cm for bladder, rectum, penile bulb, and bone, respectively. Across both SF workflows, adaptive plans were clinically comparable to the standard workflow, with mean dose differences from -1.7% to 4.6% and mean monitor unit differences remaining under 2%. Failure modes and effects analysis identified 3 high-risk failure modes: mislabeling diagnostic MR scans (RPN=39), case tracking lapses (RPN=29), and incorrect RED assignment (RPN=22), all mitigated through workflow refinements and training. The diagnostic MR SF workflow has been clinically implemented, treating 22 patients without failures. CONCLUSIONS: Both SF workflows eliminated the need for simulation, streamlining adaptive prostate SBRT without compromising plan quality. The template-based workflow further improved patient access by removing imaging prerequisites.
引用
- Côté N, Sun L, Nagar H, et al. Simulation-Free Adaptive Prostate Stereotactic Body Radiation Therapy on Magnetic Resonance-Linac: Technical Feasibility and Clinical Experience. Int J Radiat Oncol Biol Phys. 2026. PMID: 41932402. doi:10.1016/j.ijrobp.2026.03.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。